ライフサイエンスコーパス: was not significantly

1 However, the soil C loss was not significantly affected by any of the interactions, al

2 ulations, in vitro uptake of iodide by NIS-expressing cells was not significantly affected by ICM.

3 ICC was not significantly affected by liver expertise, LI-RADS fa

4 copherols), whereas the concentration of phenolic compounds was not significantly affected.

5 The amplitude modulation was not significantly altered by head-on-trunk position, but

6 with reductions in BOT-2 motor proficiency (p=0.0321), but was not significantly associated in girls and urinary thiocya

7 Systemic corticosteroid therapy was not significantly associated with a clinical improvement.

8 among marginal patients, receipt of noninvasive ventilation was not significantly associated with differences in 30-day m

9 However, viral diversity was not significantly associated with increased breadth in co

10 Preoperative hemoglobin A1c was not significantly associated with mortality or adverse ev

11 d abdominal obesity, BPF or BPS, at current exposure level, was not significantly associated with obesity in U.S. adults.

12 pital vascular complication rate was 1.0%, and this outcome was not significantly associated with recent femoral proporti

13 Among black donors, older age was not significantly associated with risk (HR, 0.88; 95% CI,

14 Mortality was not significantly associated with the LCT-13910 C/T genot

15 ature for envisioned clinical application, the IC50 of MEAN was not significantly changed in several drug-resistant cell

16 When RP was performed, ridge width loss was not significantly decreased, but the loss was evenly dist

17 The mean (SD) BMI z score was not significantly different at 12 months (control group,

18 The success rate was not significantly different at 6 months (81% vs 61%, P =

19 on between betaPPA at baseline and visual field progression was not significantly different between AD and ED eyes (beta

20 e of cerebral palsy or other major neurological impairments was not significantly different between groups.

21 The rate of peripapillary choroidal thinning was not significantly different between healthy and glaucoma

22 Crude 90-day mortality was not significantly different between patients managed with

23 The 30-day composite end point was not significantly different between suction-based extract

24 Postprogression OS was not significantly different between the chemotherapy plus

25 fter treatment, gametocyte sex ratio became male-biased and was not significantly different between the DP and DP-PQ grou

26 he visual analog scale (VAS) during blue light illumination was not significantly different between the microneedle and s

27 Change in personality (ie, slope), however, was not significantly different between the nonimpaired and t

28 al infarction (MI), or nonperiprocedural ipsilateral stroke was not significantly different between therapies (OR: 1.22;

29 ous height to crypt depth ratio in distal duodenal biopsies was not significantly different between those who received th

30 The incidence of IRIS, and drug toxicity was not significantly different between trial arms.

31 sted rate of in-hospital death or withdrawal from treatment was not significantly different between urban and rural hospi

32 WTP was not significantly different between villages that had par

33 PrEP efficacy was not significantly different between women with detected G

34 n the samples treated with chlorine-based disinfectants and was not significantly different compared with the nondisinfec

35 t the genetic correlation between the P wave and PR segment was not significantly different from 0 (rG=-0.03 [0.16]).

36 percentage of absorption of alpha-carotene from raw carrots was not significantly different from beta-carotene when adjus

37 The FAZ area was not significantly different from normal (all P >/= .24).

38 receiver-operator characteristic curve (AUC) of UMT (0.84) was not significantly different from that of BinaxNOW Pf (0.8

39 ume of total tumor before treatment (503.1 mm(3) +/- 204.6) was not significantly different from those after treatment (P

40 Following corneal inoculation of mice, the mutant was not significantly different from wild-type virus in terms

41 ercentage decrease in prevalence after age 12 was 1%, which was not significantly different from zero (95% confidence int

42 Thirty-day survival was not significantly different in patients who received a hi

43 The incidence of serious adverse events was not significantly different in the MABp1 group and placeb

44 The risk associated with insulin detemir was not significantly elevated (HR, 1.17; 95% CI, 0.77 to 1.7

45 For heroin, the mean was not significantly greater than 0, but the confidence inte

46 NTERPRETATION: In young children, tuberculosis disease risk was not significantly increased, and QFT reversion was common

47 dnisone was reasonably well tolerated, but overall survival was not significantly longer for patients with metastatic cas

48 Progression of mean cIMT was not significantly reduced with metformin (-0.005 mm per y

49 Total severity of ADHD-traits was not significantly related to DTI metrics but inattention

50 ility over time, although clonal stability (Sorensen index) was not significantly time dependent within this interval.